Shionogi celebrates antibiotic win in pneumonia just ahead of its date with FDA regulators
Just weeks before Shionogi is scheduled to hear back from the FDA on treating complicated urinary tract infections with its antibiotic, the Japanese pharma has …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.